Biotech

All Articles

ReNeuron leaving behind goal swap after skipping fundraising target

.ReNeuron has joined the lengthy listing of biotechs to leave behind London's goal securities market...

MBX declare IPO to take challenger to Ascendis right into period 3

.MBX Biosciences has included in the current flurry of IPO filings. The biotech, which submitted its...

FDA increases probing into Lykos' MDMA trials: WSJ

.For Lykos Therapeutics and the provider's potential MDMA-assisted treatment for post-traumatic stre...

Gene editor Volume giving up 131 employees

.Only days after genetics editor Volume Biosciences introduced confidential working cuts, a more cle...

Repare gives up 25% of personnel as biotech halts preclinical R&ampD

.Repare Therapy is laying off an one-fourth of its own workforce as the oncology biotech downsize it...

J &amp J files for FDA approval of $6.5 B autoimmune medicine

.Johnson &amp Johnson has actually gotten one more action toward noticing a profit on its $6.5 billi...

Gain's stage 1 gain paves way to confirm Parkinson's medicine's worth

.Gain Therapeutics has established its own direct showing the performance of its own Parkinson's dis...

Actinogen reports new stage 2 information to save depression drug

.Actinogen Medical's chances-- and supply rate-- have rebounded a little coming from previously this...

Pfizer as well as Crown jewel incorporate Ratio to multibillion-dollar formula

.Front Runner Pioneering as well as Pfizer have incorporated Ratio right into their 10-program relat...

Bayer pens $547M contract to push perimeters of noncoding RNA

.Bayer managers were actually keen to anxiety to Strong this summer season that the German pharma ti...